Product Information

PREGABALIN 150 MG CAPSULE is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.0510 per EA under NDC 72205001590. Its NADAC has been published 366 times since Aug 21, 2019.

FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Pregabalin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for PREGABALIN 150 MG CAPSULE has been published 366 times since Aug 21, 2019, and over the history we have for it it has declined 73.0%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.